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PEDIATRIC NEW PERSPECTIVE
A new approach to assessing the health benefit from
obesity interventions in children and adolescents:
the assessing cost-effectiveness in obesity project
MM Haby1, T Vos2, R Carter1, M Moodie1, A Markwick3, A Magnus3, K-S Tay-Teo1 and B Swinburn4
1Program Evaluation Unit, School of Population Health, The University of Melbourne, Parkville Victoria, Australia; 2School
of Population Health, University of Queensland, Herston, Qld, Australia and Chronic Disease Surveillance and
Epidemiology, Public Health Branch, Department of Human Services, Melbourne Victoria, Australia; 3Chronic Disease
Surveillance and Epidemiology, Public Health Branch, Department of Human Services, Melbourne Victoria, Australia and
4School of Exercise and Nutrition Sciences, Deakin University, 221 Burwood Highway, Melbourne Victoria, Australia
Objective: To report on a new modelling approach developed for the assessing cost-effectiveness in obesity (ACE-Obesity)
project and the likely population health benefit and strength of evidence for 13 potential obesity prevention interventions in
children and adolescents in Australia.
Methods: We used the best available evidence, including evidence from non-traditional epidemiological study designs, to
determine the health benefits as body mass index (BMI) units saved and disability-adjusted life years (DALYs) saved. We
developed new methods to model the impact of behaviours on BMI post-intervention where this was not measured and the
impacts on DALYs over the child’s lifetime (on the assumption that changes in BMI were maintained into adulthood). A working
group of stakeholders provided input into decisions on the selection of interventions, the assumptions for modelling and the
strength of the evidence.
Results: The likely health benefit varied considerably, as did the strength of the evidence from which that health benefit was
calculated. The greatest health benefit is likely to be achieved by the ‘Reduction of TV advertising of high fat and/or high sugar
foods and drinks to children’, ‘Laparoscopic adjustable gastric banding’ and the ‘multi-faceted school-based programme with an
active physical education component’ interventions.
Conclusions: The use of consistent methods and common health outcome measures enables valid comparison of the potential
impact of interventions, but comparisons must take into account the strength of the evidence used. Other considerations,
including cost-effectiveness and acceptability to stakeholders, will be presented in future ACE-Obesity papers. Information gaps
identified include the need for new and more effective initiatives for the prevention of overweight and obesity and for better
evaluations of public health interventions.
International Journal of Obesity (2006) 30, 1463–1475. doi:10.1038/sj.ijo.0803469
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Introduction
There is now a widespread awareness of the problem of
childhood and adolescent obesity1,2 and many governments
are now seeking to invest in prevention and management
programmes. Concurrently, there is also an increasing
recognition of the need for health investments to be
informed by the best available evidence of effectiveness
and cost-effectiveness.3–5 Unfortunately, for the prevention
of childhood obesity, the traditional evidence base of
intervention effectiveness trials is very small in volume
(fewer than 25 studies), very narrow in approach (mainly
primary school programmes), shows very limited impact,6,7
and evidence of cost-effectiveness is almost non-existent.8,9
New approaches are urgently needed to fill this gap in the
evidence base so that decision-makers have some evidential
basis for making policy and funding decisions beyond the
usual drivers of historical precedence, potential political
gains and the lobby power of vested interests.
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Services in Victoria, Australia, commissioned the assessing
cost-effectiveness in obesity (ACE-Obesity) project in 2004.
The aim of the project was to assist state and national policy-
makers by providing evidence of the effectiveness and cost-
effectiveness of selected obesity prevention interventions,
particularly among children and adolescents.
The methods for the ACE-Obesity project, along with
previous ACE studies in cancer, heart disease and mental
health,4,10–12 draw upon the theories of priority setting13 and
combine technical rigour with due process. Technical rigour
is obtained by using the best available epidemiological and
economic data when analysing the effectiveness, population
impact, costs and cost-effectiveness of interventions and by
using a standardized evaluation protocol to ensure transpar-
ency and comparability of outcomes across interventions.
Due process is achieved by involving stakeholders in a
project working group, taking into account ‘2nd stage filter’
criteria which are the broader considerations that are
important in decision-making but less amenable to quanti-
fication (strength of evidence, acceptability to stakeholders,
feasibility of implementation, sustainability, impact on
equity as well as potential positive and negative side-
effects5,13) and seeking consensus decisions after informed
discussion and debate.
For previous ACE projects, there was sufficient trial
evidence available for the technical analyses to model
interventions for the Australian context. However, to evolve
the previous ACE methodologies for use in childhood and
adolescent obesity posed several substantial challenges: the
limited trial data meant that other forms of evidence would
have to be used; models for assessing the impact of
behaviour changes on energy balance and weight change
would have to be developed, and; methods for extrapolating
reductions in body mass index (‘BMI savings’) in childhood
into reductions in disability-adjusted life years (‘DALY
savings’) in adulthood would also have to be developed.
This work therefore involved the development of an
integrated series of new methodologies for the obesity
context that could be widely applied across many different
obesity intervention scenarios. This work represents a
significant advance on previous cost-effectiveness work in
adults and children8,14 because it includes public health
interventions without randomized controlled trial evidence,
assesses interventions using common health outcomes (BMI
and DALYs) and includes the expected impact on almost all
diseases that have been shown to be causally related to
obesity.15
It is only when all interventions are assessed using
common health outcomes that fair comparisons can be
made across interventions and with interventions for other
disorders. This has not been possible before for obesity and
was only achievable through modelling as BMI and obesity-
related disease outcomes are not routinely measured when
assessing the effectiveness of interventions. Although this
modelling has been done using Australian data for demo-
graphics, burden of disease, BMI distribution and interven-
tion uptake the work could be readily adapted for use in
other countries by keeping the same structure but using
country-specific data for these inputs.
The purpose of this paper is twofold: to provide an
overview of the ACE-Obesity approach and associated
methods for calculating the likely impact of interventions
on BMI and DALYs and, as an example, to provide the health
benefit results for 13 obesity interventions modelled for the
Australian population of children and adolescents. An
assessment of the strength of evidence (level and quality)
used in the calculations of health benefit is also reported.
Methods
Overview of ACE-Obesity aims and process
The ACE methodology aims to help decision-makers (mainly
within governments) to set priorities by combining techni-
cally rigorous analyses with due process. The question posed
by the ACE-Obesity project was ‘What are the best options
towards which state and national resources should be
directed to reduce unhealthy weight gain in children and
adolescents in Australia?’ Although the project was funded
by the Victorian State Government, it used the target
population of all Australian children and adolescents aged
5–19 years. The reference year for all calculations was 2001
(latest year for which key data were available) and an annual
discount rate of 3% was used for calculating the present
value of the projections.3
A working group was established of representatives from
state and federal health departments and other government
agencies and departments, representatives from key non-
governmental organizations (including a health consumer
organization), and academics with particular areas of
expertise. They met nine times over the 2 years of the
project and provided substantial input into: the selection of
the interventions to be scoped and then taken to full
analyses; the methodologies developed for the modelling;
the assumptions involved in the models, including uncer-
tainty parameters; and the judgements about the 2nd stage
filter criteria for each intervention.
Interventions
A list of 22 potential intervention areas was drawn from the
literature, existing initiatives and programmes and the
Australian Government’s strategic plan for obesity.16 As part
of the ACE-Obesity project we had the resources to evaluate
the effectiveness and cost-effectiveness of 13 different
obesity interventions in children and adolescents. Priority
was given to public health interventions that met pre-agreed
selection criteria; two of the most significant being (i)
relevance to current policy decision-making and (ii) avail-
ability of evidence of effectiveness/efficacy to support the
analyses. Judgements about which interventions to include
were made by the project working group and supported by
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‘scoping reports’ prepared by the research team. Although
there was very little evidence to support some of the
included interventions, they were included owing to their
importance to current policy decision-making (e.g. Active
After School Communities). Some clinical interventions
were included for benchmarking purposes (e.g. Laparoscopic
adjustable gastric banding). Intervention areas were most
commonly excluded because a particular intervention could
not be clearly described (e.g. active recreation), owing to lack
of evidence (e.g. interventions in early child care) or because
several interventions from that setting (e.g. schools) were
already included.
The interventions chosen for analysis by the project
working group are shown in Table 1. Also shown is the
broad intervention setting, the target population for the
intervention and the likely number of participants based on
Australian population figures in 2001 and likely take-up
rates.
Assessment of health gain
DALYs saved over the child’s lifetime was chosen as the
measure of health gain for the ACE-Obesity project. This
measure was chosen because it captures both morbidity and
mortality effects and because baseline information on health
status is available for Australia.43,44 It also allows comparison
with obesity prevention interventions in adults, as well as
with interventions for other conditions for which cost-
effectiveness ratios have been calculated using the ACE
approach.4,10 We also calculated the total age-specific BMI
units (kg/m2) that could be saved by the intervention.
The first step was to calculate the BMI units (kg/m2) that
the intervention could save for the individual and the
population and the second step was to convert this post-
intervention BMI units saved to lifetime DALYs saved.
Measurement of BMI units saved. Where possible, BMI
change post-intervention was determined directly from trial
data. Where there was more than one relevant (and similar)
trial, we attempted to use meta-analysis to determine the
average BMI benefit.45 In practice, the degree of hetero-
geneity in intervention design (e.g. ‘Multifaceted school-
based interventions’) prevented this and analyses were more
often based on the results of one trial.
Where controlled trials were not available, effectiveness
was modelled using the best available evidence and/or
plausible assumptions. We make all of our assumptions
explicit in reporting of the effectiveness and cost-effective-
ness results in the individual intervention papers. For some
interventions only changes in behaviour (e.g. an increase in
physical activity) were reported in the trial or in the
programme evaluation. Examples of these interventions
include ‘Reduction of TV advertising’, where the randomized
controlled trial only reported changes in food and drink
choice and the ‘Walking School Bus’, where only frequency
and duration of walking was reported for those participating
in the intervention. To enable us to evaluate these interven-
tions, we modelled the relationship between behaviour
change, energy balance and BMI using the best available
evidence. The method for this is described below.
Behaviour change to energy imbalance The logic model for
the pathways through which behaviour changes influence
body weight has previously been published.46 Interventions
that change energy intake operate through changes in either
the weight (g) or the energy density (kJ/g) of food and
beverages consumed (or both). Interventions that change
energy expenditure are assumed to operate through changes
in sedentariness or changes in physical activity (or both).
There is now substantial experimental evidence that
changing the energy density of foods and beverages changes
total energy intake because there is little or no compensation
through change in the total weight of food eaten.47,48 This is
supported by monitoring data in Australian children which
showed that the 13% increase in energy intake from 1985 to
1995 was owing to the 15% increase in energy density with
no changes in the weight of food eaten.49
We used the Australian 1995 National Nutrition Survey
(NNS95)50 to determine the weight and energy density of the
total diet (excluding water) for children 2–18 years from
‘core’ and ‘non-core’ foods and beverages according to the
Australian Guide to Healthy Eating.51,52 We assumed that
any reductions in non-core food consumption (e.g. owing to
reduced promotion of the products) were replaced by an
equivalent weight of core foods so that the total weight of
food was not altered. The same assumptions were made for
beverages, but the impact on BMI was based on data from
Ludwig et al.53
Unless there were published trial data on the changes of
physical activity or sedentary behaviours on weight or BMI,
we modelled the impact of such interventions using the
published energy costs of activity.54 The metabolic equiva-
lent values (METs) for an activity (such as walking) were
subtracted from the MET value for resting quietly (1.0) to
give the net MET difference for modelling.
Energy imbalance to weight and BMI Once an energy deficit
had been determined, the next step was to model its impact
on changes in weight using validated coefficients for such
calculations,46 whereby a 10% change in energy balance
results in a 4.5% change in body weight (95% confidence
interval 3.8–5.1).46 We used the data from the NNS9550 to
translate mean changes in weight to mean changes in BMI,
assuming no change in height.
Modelling of DALYs saved. We calculated the DALYs saved
owing to the interventions as the difference in future
mortality and morbidity outcomes between a baseline
scenario (base case), which represents current practice, and
the intervention option. Differences in mortality and
morbidity were based on changes in the age-specific BMI
distribution of the target population over their remaining
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Table 1 Interventions chosen for analysis (grouped by setting), target population and strength of evidence (definitions in Table)
Intervention and setting16 Target population and number of childrena Strength of
evidence category
Comments on studies used and likelihood of bias
Child care
1. Active After School Communities
Programme17
Primary school children in grades
prep to 6 (age 5–11 years)
NE99 000
None Evidence used in the modelling is based mostly on level IV, parallel evidence and
programme logic. Other studies of physical activity within the school setting have
shown no significant effect on BMI,18,19 except for very intensive interventions
(1.25 h per day for 14 weeks).20
Schools
2. Multi-faceted school-based programmes,
including education to improve nutrition
and increase physical
activity without an active PE component21
Children in primary school grade 1
(age 6 years) – 2 year programme
NE114 630
Limitedb One non-RCT that showed a statistically significant BMI benefit for girls only.21
Variations of Know Your Body studies have been trialled across the world with
mixed results.
3. Multi-faceted school-based programmes,
including education to improve nutrition
and increase physical
activity with an active PE component22
Children in primary school grade 1
(age 6 years) – 3 year programme
NE114 630
Limitedb One non-RCT that showed a large and statistically significant BMI benefit for both
boys and girls.22 Variations of Know Your Body studies have been trialled across the
world with mixed results.
4. Multi-faceted school-based programme
targeted at overweight and obese
children23
Overweight or obese children aged
7–10 years attending a combined
primary/secondary school
NE3800
Limitedb One small non-RCT in USA, published in 1985.23
5. School-based education programme
to reduce consumption of carbonated
(fizzy) drinks24
Children in primary school grades 2 to 6
(age 7–11 years)
NE595 000
Limitedb Two RCTs in total. One UK RCT, used for this analysis, that showed statistically
significant decrease in prevalence of overweight and obesity but not mean BMI.24 One
US RCT that showed a significant reduction in mean BMI among the upper baseline-
BMI tertile, but not overall.25
6. School-based education programme
to reduce TV viewing26
Children in primary school grades 3 and 4
(age 8–10 years)
NE268 600
Inconclusive One small RCT that showed a statistically significant reduction in mean BMI.26
Supported by another RCT where reduction in TV viewing accounted for the
reduction in BMI in a multi-faceted school-based intervention.27 The authors are
aware of one larger US RCT conducted by Robinson (1999–2002), which has not been
published. Attempts to discover the results of this RCT have been unsuccessful and the
authors have assumed no significant result. An Australian RCT, results as yet
unpublished, but shown to have no effect on TV viewing or BMI.
Schools/neighbourhoods and community organizations
7. TravelSMART schools28 Children in primary school grades 5 and 6
(age 10–11 years)
NE267 700
Weak One small pilot study (level III-3 study design) with very low response rate (35%).28
Only measured change in % of students using active transport. BMI not measured.
Would benefit from further research and/or pilot studies before implementation.
8. Walking School Bus29 Primary school children in grades prep to 2
(age 5–7 years)
NE7840
Weak Modelling based on level IV evidence.30 Further effectiveness data sought but this
does not appear to support its effectiveness. Would benefit from further research and/
or pilot studies before implementation.
Media and marketing
9. Reduction of TV advertising of high fat
and/or high sugar foods and drinks to
children (up to 14 years)
All Australian children aged 5–14 years
NE2.4 million
Limitedc Single RCT assessing food choice after reduced advertising.31 Supportive parallel
evidence in toys, smoking and alcohol advertising bans exists. Cross-sectional studies
used for evidence of impact of food choice on BMI. Implementation of this
intervention should be accompanied by an appropriate evaluation budget.
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life span. To do this we took all children aged 5–19 years
from the NNS95 as the cohort of children for the model,
since data on measured BMI are available and representative
of the Australian population in 1995.50 For all analyses BMI
values were log-transformed and 6 years of cohort effect were
added to approximate 2001 BMI values. We calculated future
predicted BMI values for this cohort of children in 5-year
increments to 100 years of age by adding age effects to the
values from 2001. We calculated both the cohort and age
effects from serial cross-sectional studies of BMI in children
and adults in Australia using multiple linear regression.
These calculations assume that the relative contribution to
BMI of year of birth (cohort) and age remain constant over
time. These values of BMI represent the base case.
For the intervention scenario, we adjusted the base case
BMI values in 2001 by subtracting the average BMI reduction
attributable to the intervention in the relevant target group.
Thus, for an intervention aimed at all 5–9 year olds that
achieved a reduction in BMI of 0.2 kg/m2 all 5–9 year olds in
the cohort have 0.2 subtracted from their 2001 BMI values. If
the intervention was targeted at obese children, only those
children within the cohort that fell into that category would
have 0.2 subtracted. We then log-transformed the BMI values
and the projections into the future were recalculated by
adding the age effects as described above. These values of
BMI represent the intervention option.
Potential impact fraction We determined the impact of the
change in the BMI distribution on mortality and morbidity
from the potential impact fraction (PIF).55 The PIF is the
proportional change in expected disease or death, that is,
attributable to a change in exposure to the risk factor in the
population. It is calculated from the proportion of children
in each BMI category (e.g. 21–21.99, 22–22.99 and so on) in
the base case and with the intervention, and from the
relative risk (RR) of disease for the specific BMI category
compared to a reference category of BMI 21.15,55 BMI values
below 21 are included in the reference category of BMI 21 (as
used by the World Health Organization for their Global
Burden of Disease Study).
The diseases for which PIFs were calculated are ischaemic
heart disease, ischaemic stroke, hypertensive heart disease,
type 2 diabetes, osteoarthritis, endometrial cancer, colon
cancer, post-menopausal breast cancer and kidney cancer.
These diseases were included because: (i) they have been
shown to be causally related to obesity;15 (ii) continuous RRs
are available (i.e. per 1 kg/m2 increase in BMI);15 and (iii)
they are included in the 2003 Australian and/or 2001
Victorian Burden of Disease Study estimates of disease risk
owing to high BMI.44 PIFs were calculated in Stata (Inter-
cooled Stata, version 8.0, StataCorp) by sex and 5-year age
group over the remaining lifespan of the cohort.
The RR estimates15 were applied to both deaths and disease
prevalence and assume that: (i) excess disease risk occurs
only at BMIs 421 kg/m2 and only from 25 years of age;15 (ii)
shifts in the population distribution owing to obesityT
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interventions do not lead to an increase in the prevalence of
underweight (BMIo18.5 kg/m2) which has its own health
risks;15 (iii) RR estimates are not changing over time; (iv)
risks for the 30–44 year age group apply to 25–29 year olds;
(v) RRs are constant within a given age group; and (iv) the
risk of disease is exponentially related to BMI.15 Disease risks
for underweight (BMI o18.5 kg/m2) are not included.
The BMI to DALYs model To determine the change in
DALYs resulting from an intervention deterministic Markov
modelling techniques are used. The model takes the current
prevalent cohort of children and adolescents (age 5–19 years)
in 2001 and follows them for their remaining life span until
death (or age 100 years). New cases are not added. The model
was constructed in Microsoft Excel with some inputs (PIFs,
projected mortality rates) calculated in Stata.
The backbone of the model is a separate cohort life table
for each sex (male, female) and 5-year age group (5–9, 10–14
and 15–19 years), giving six life tables in total for the base
case. These six tables, constructed in Excel 2000, are repeated
for the intervention scenario and the difference between the
intervention and base case gives the DALYs saved owing to
the intervention.
Base case (current practice) scenario The base case assumed
continuation of current trends in mortality and BMI
distributions and, implicitly therefore, continuation of past
trends in practice of obesity prevention and treatment. The
years of life lived in the base case were calculated from
projected Australian all-cause (total) age-specific mortality
rates.56 Projections were based on past mortality trends
(1979–2002) with no explicit modelling of the effect of
changes in risk factors and assumed continuation of trends
to 2031, after which mortality rates were kept constant.
Years of life lived were adjusted for disease-related
disability for each sex and age, determined from the
Victorian Burden of Disease Study for 2001.44 Total prevalent
years lived with disability (YLD) for each sex and age group
were calculated as prevalencedisability weight and were
converted to rates by dividing by Victorian population
figures. Total mortality and disability rates were extrapolated
from 5-year to 1-year age groups for input into the life tables
using the function (linear, exponential or polynomial) that
gave the best R2-value.
Intervention scenario For the intervention scenario we
calculated the mortality and prevalent YLD rates for
obesity-related diseases as the rate in the base case (1-PIF)
for each age and sex category. For most diseases it was
assumed that current prevalent YLD rates are a good
approximation of future rates. However, for ischaemic heart
disease, ischaemic stroke and type 2 diabetes, trends in
incidence were accounted for to 2031, after which they were
kept constant.56 The trends show decreasing rates of
prevalent YLD for ischaemic heart disease and ischaemic
stroke, but increasing rates for type 2 diabetes, largely owing
to expected increases in the prevalence of obesity over the
projection period.56 After applying the PIFs we recalculated
years of life lived and disability-adjusted years lived. The
difference between the intervention scenario and the base
case gives the years of life saved and DALYs saved by the
intervention.
Targeted interventions For interventions targeted at the
overweight or obese group of children the average popula-
tion mortality and YLD rates used in the BMI to DALYs
model would underestimate the true disease experience of
these higher risk groups. Therefore, correction factors were
calculated for: (i) overweight or obese children; and for (ii)
obese children separately by disease, sex, 5-year age group
and cohort (aged 5–9, 10–14 and 15–19 years in 2001). This
was done by determining the proportion of the disease
burden in the whole population at each age that is
contributed by the top percentiles of the BMI distribution
that correspond with the prevalence of obesity and/or
overweight in children targeted for intervention. For exam-
ple, if the prevalence of obesity in 5- to 9-year-old children
was 10% we calculated at each successive age the proportion
of disease burden owing to elevated BMI that occurs in the
top 10% of the BMI distribution. If in this example we found
that 25% of the total amount of disease attributed to BMI
occured in the top 10% of the BMI distribution, the
correction factor was 25/10¼ 2.5. In other words, children
in the top 10% of the BMI distribution will experience 2.5
times the rate of the population average disease rates and
treatment costs. When applied in the model the correction
factors for the overweight or obese group resulted in an
increase in the DALYs saved of 92–250% depending on the
cohort, sex and BMI reduction tested.
Economic analyses
Economic analyses were also conducted and whereas the
results are not shown here, brief mention is made of the
methods to provide a complete picture of the ACE-Obesity
approach. With each of the specified interventions, costs
were estimated based on a societal perspective and with the
intervention under ‘steady-state conditions’ (i.e. fully im-
plemented and operating in accordance with its efficacy
potential). Detailed intervention pathway analysis was used
to specify all steps in an intervention and the probability of
associated resource use. Unit costs were sourced from the
most accurate sources for the 2001 reference year. Interven-
tion costs were assessed as additional expenditure (savings)
against current practice. Net incremental cost-effectiveness
ratios were calculated as the ‘net cost per DALY saved’,
following consideration of cost-offsets or the savings in
health care costs arising from a reduction in obesity-related
diseases as a consequence of the intervention.
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Uncertainty analysis
We used @RISK software (version 4.0, Palisade Corporation)
to conduct simulation modelling (with Monte Carlo sam-
pling) to calculate 95% uncertainty ranges around the
benefits, costs and cost-effectiveness ratios. The probability
distributions around the input variables were based on the
range of parameter values and/or standard errors obtained
from the literature, together with expert advice on the likely
scenarios under Australian conditions.
In the BMI to DALYs model, there is uncertainty around
many of the input values, such as the RRs of disease,
mortality rate projections and BMI projections. Ideally, we
would have included uncertainty around all inputs in the
@RISK analyses. However, this is a difficult and time-
consuming task and thus, to date, we have only conducted
simple one-way uncertainty analyses in the BMI to DALYs
component of the modelling. Consequently, the only
uncertainty around the resultant DALYs saved for each
intervention is due to the uncertainty around the impact
of each intervention on BMI.
Strength of evidence
When assessing the strength of evidence used to calculate
the health benefit, it became clear that the existing ACE
approach10 based on the grading of the level57 and quality of
evidence into three categories (sufficient evidence, limited
evidence, and inconclusive evidence, as set out in the left
hand column of Table 2) did not work very well for obesity
prevention interventions. Thus, a new classification system
was developed (Table 2), which combined the traditional
classification of evidence based on epidemiologic study
design, with other types of evidence that would not
ordinarily be captured, for example, parallel evidence and
epidemiological modelling to BMI based on a mix of
evidence types. This revised classification draws on the work
of Hawe and Shiell 199558 and Swinburn et al. 20055 and also
reflects aspects of other evidence frameworks.59–61
Results
Results for the assessment of health benefit and strength of
evidence for the 13 interventions analysed are shown in
Tables 1 and 3. The intervention with the biggest impact on
an individual’s BMI is the clinical intervention ‘Laparoscopic
adjustable gastric banding’ for morbidly obese adolescents
(Table 3). However, the intervention with the biggest
population impact is the public health intervention ‘Reduc-
tion of TV advertising of high fat and/or high sugar foods
and drinks to children’. Although the individual impact of
this intervention is relatively small (Table 3), the number of
children affected is large (Table 1), resulting in savings of
around 400000 total BMI units or 37 000 total DALYs (Table 3).
Table 2 Classifying the strength of the evidence – based on study design57 and quality
Evidence from level I–III study designsa,b Evidence from level IV studiesa, indirect or parallel evidence5 and/or from
epidemiological modelling using a mixture of study designs
1. ‘Sufficient evidence of effectiveness’ 3. ‘Limited evidence of effectiveness’
K The effect is unlikely to be due to chance or bias:
K evidence from a level I study design; several good quality level
II studies; or several high quality level III-1 or III-2 studies from
which effects of bias and confounding can be reasonably
excluded.
K Sound theoretical rationale and programme logic; and
K Level IV studies, indirect or parallel evidence for outcomes; or
K Epidemiological modelling to the desired outcome (BMI) using a
mix of evidence types or levels.
The effect is unlikely to be due to chance.
Implementation of this intervention should be accompanied by an
appropriate evaluation budget.
2. ‘Limited evidence of effectiveness’ 4. ‘Weak evidence of effectiveness’
K The effect is probably not owing to chance.
K Bias cannot be excluded as a possible explanation:
K evidence from one level II study of uncertain or indifferent
quality; one level III-1 or III-2 study of high quality; several
level III-1 or III-2 studies of lower quality; or sizeable number of
level III-3 studies of good quality and consistent in suggesting
an effect.
K Sound theoretical rationale and programme logic; or
K Level IV studies, indirect or parallel evidence for outcomes; or
K Epidemiological modelling to the desired outcome (BMI) using a
mix of evidence types or levels.
The effect is probably not due to chance but bias cannot be excluded
as a possible explanation.
Would benefit from further research and/or pilot studies before
implementation.
5. ‘Inconclusive evidence of effectiveness’ 6. ‘No evidence of effectiveness’
No position could be reached on the presence or absence of an effect
of the intervention – only level III studies available but they are few and
of poor quality.
No position could be reached on the likely credentials of this
intervention. Further research may be warranted.
Abbreviations: BMI, body mass index. Boxes are numbered according to their order in the evidence hierarchy from 1 (strongest evidence) to 6 (no evidence). aThese
evidence classifications are based on those of the National Health and Medical Research Council of Australia57: I, systematic review of RCTs; II, one or more properly
designed RCTs; III, studies with other (non-randomized) controls; IV, case series, pre-test and/or post-test. bSee Carter et al.10 or Haby et al.12 for full details for this
column.
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Table 3 Impact of the interventions on BMI (post-intervention) and DALYs saved (over the child’s lifetime)
Intervention BMI reduction per child (kg/m2) Total BMI units saved DALYs saved per child Total DALYs saved
9. TV advertising 0.17 (0.05, 0.33) 400 000 (170 000, 700 000) 0.014 (0.006, 0.022) 37 000 (16 000, 59 000)
13. Laparoscopic adjustable gastric
banding
13.9 (9.9, 17.95)a 55 000 (13 000, 140 000) 3.29 (2.98, 3.46) – boys
2.70 (2.54, 2.75) – girls
12 000 (5000, 25 000)
6. TV viewing 0.45 (0.17, 0.73)a 122 000 (43 000, 194 000) 0.03 (0.01, 0.05) 8600 (4500, 12 400)
3. Multi-faceted school-based
including active PE
1.1 (0.82, 1.38)a 124 000 (53 000, 214 000) 0.08 (0.06, 0.09) – boys
0.07 (0.05, 0.08) – girls
8000 (3500, 13 500)
5. Fizzy drinks 0.13 (0.08, 0.34)a 69 000 (46 000, 235 000) 0.01 (0.007, 0.03) 5300 (1300, 17 000)
11. Targeted family-based
programme
1.70 (0.68, .72)a 3400 (1200, 8300) 1.32 (0.60, 1.92) – boys
0.99 (0.45, 1.36) – girls
2700 (1000, 6300)
2. Multi-faceted school-based
without active PE
0.14 (0.20, 0.48)a – boys 7200 (11 000, 32 000) – boys 0.01 (0.02, 0.04) – boys 500 (600, 2100) – boys
0.31 (0.0004, 0.62)a – girls 16 000 (300, 45 000) – girls 0.02 (0.01, 0.04) – girls 1000 (200, 2800) – girls
23 000 (9000, 77 000) – all 1600 (250, 4900) – all
10. Targeted GP programme 0.25 (0.12, 0.62)a 2300 (1100, 6000) 0.06 (0.031, 0.16) – boys 510 (90, 1200)
0.046 (0.024, 0.11) – girls
1. Active After School Prep to Grade 4: 0.07 (0.03, 0.15) – boys & girls 4200 (1700, 9100) Prep to Grade 4: 0.006 (0.003, 0.011) – boys 450 (250, 770)
Communities Grades 5 and 6: 0.08 (0.03, 0.18) – boys 0.005 (0.002, 0.011) – girls
0.09 (0.04, 0.19) – girls Grades 5 and 6: 0.007 (0.003, 0.016) – boys
0.006 (0.004, 0.014) – girls
12. Orlistat therapy 0.86 (0.37, 1.34)a 600 (80, 3000) Age 12–14 years: 0.78 (0.34, .08) – boys 450 (67, 1800)
0.59 (0.27, .84) – girls
Age 15–16 years: 0.54 (0.17, 0.87) – boys
0.55 (0.28, 0.86) – girls
4. Targeted multi-faceted school-
based programme
0.52 (0.10, 0.94) 2000 (370, 3500) 0.08 (0.02, 0.25) 360 (90, 1100)
7. TravelSMART Walking: 0.07 (0.02, 0.18) – boys & girls 470 (190, 1000) Walking: 0.005 (0.002, 0.015) – boys 50 (33, 72)
Cycling: 0.02 (0.01, 0.04 – boys 0.005 (0.003, 0.013) – girls
0.03 (0.01, 0.04) – girls Cycling: 0.002 (0.001, 0.003) – boys
0.003 (0.001, 0.004) – girls
Public transport: 0.0007 (0.0005, 0.001) – boys
Public transport: 0.007 (0.004, 0.011) – boys 0.0009 (0.0003, 0.001) – girls
0.008 (0.004, 0.012) – girls
8. Walking School Bus 0.03 (0.01, 0.11) 270 (40, 1300) 0.003 (0.00034, 0.0086) – boys 30 (7, 104)
0.0018 (0.00072, 0.0079) – girls
Abbreviations: BMI, body mass index; DALYs, disability-adjusted life years; GP, general practitioner; PE, physical education Note: interventions are ordered by impact on total DALYs saved; intervention
number is from Table 1. Unless otherwise stated, values are medians and ranges are 95% uncertainty intervals obtained from @RISK. Values are given to two significant figures. aMean (95% confidence
interval).
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Although there are multiple considerations in choosing an
eventual portfolio of interventions to reduce childhood
obesity, some of the factors can be displayed graphically to
give a sense of the interplay between them. An example is
shown in Figure 1 where the strength of the evidence (from
Table 1) for the modelled interventions is plotted against its
estimated population impact (from Table 3). Options in the
top left hand corner, provide the biggest population impact
with the greatest strength of evidence and, therefore, greater
certainty of effect.
Discussion
Investing in the reduction of obesity in children and
adolescents means setting priorities. Ideally, the pro-
grammes, policies and services to be prioritized into a
portfolio of interventions should be based on the best
evidence available on the likely costs, the likely effectiveness,
the level of certainty (strength of evidence) and other
considerations important in decision-making (impact on
equity and so on).4,5 The ACE-Obesity approach aims to
provide this information to decision-makers and, in this
paper, we have provided an overview of the approach and
some of the key methodologies along with illustrative health
benefit (effectiveness) results from the modelling as applied
to 13 potential interventions for the Australian population
of children and adolescents.
At this stage, the ACE-Obesity methods and processes may
be analogous to the early modelling of the global burden of
disease in the 1990s.62 Those results had a significant effect
on reorienting global attention onto the major contributors
to the overall population disease burden. Since then, that
modelling methodology has become much more sophisti-
cated to include risk factors and attributable burdens, the
evidence base to support the modelling has improved, and
the modelling has been used to inform priorities in smaller
Strong evidence
No evidence
Sufficient evidencea Limited evidence
(study types II-III)a
Limited evidence
(study type IV or
mixed)b
Weak evidenceb No / inconclusive
evidencec
40 000 Low risk
decisione TV advertising
Total
DALY
20 000
LAGB
Multi-faceted SB + PE 
Fizzy drinks 
TV viewing
3 000 Targeted family-
based
Multi-faceted SB–PE 
Targeted GP program
500
0
Orlistat
Targeted multi-
faceted SB
TravelSMART
WSB
AASC
High risk
decisionf 
a Stronger evidence: Evidence from level I-III study designs – boxes 1 and 2 in Table 2.
b Weaker evidence: Evidence from level IV studies, indirect or parallel evidence and/or from epidemiological modelling using a 
mixture of study designs – boxes 3 and 4 in Table 2.
c Boxes 5 and 6 in Table 2.
d This axis is not to scale.
benefit d
of effectiveness
e Low risk decision – the high potential impact and strong evidence of effectiveness increases the chance of success in improving
population health.
f High risk decision – the low potential impact and weak evidence of effectiveness decreases the chance of success in improving
population health.
AASC – Active After School Communities program, GP – General Practitioner, LAGB – Laparoscopic Adjustable Gastric Banding,  
PE – active Physical Education, SB –  School-Based, WSB – Walking School Bus.
Figure 1 Total DALYs saved versus strength of the evidence base (definitions in Table 2).
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jurisdictions such as at a state level.44,63 The results of this
ACE-Obesity modelling (particularly the effectiveness, costs,
cost-utility and 2nd stage filters) will help to paint the broad
picture of priorities for intervention and we would expect
this picture to become more fine-grained and more con-
textualized over the coming years as the methods evolve, the
evidence to include in the models improves, and other
intervention scenarios are modelled. The ACE approach will
help to bridge the gap between existing decision-making for
resource allocation and policy formulation and the ideal
situation of being able to choose proven interventions based
on the best evidence possible.
Some general conclusions from this first set of ACE-
Obesity analyses can be made. Firstly, unless the individual
impact of an intervention is very large, such as for
Laparoscopic adjustable gastric banding, the number of
children and adolescents impacted by the intervention is a
critical factor in determining population impact and is one
of the reasons that the regulations to reduce food and drink
advertising, which affect all children aged 5–14 years, had a
bigger estimated effect compared to, for example, pro-
grammes in schools which are dependent on the level of
school and student uptake. Another general observation was
that the individual impact of physical activity interventions
such as the active transport programmes was smaller than
nutrition interventions such as reducing fizzy drinks. This is
not really surprising given that, for the average 8-year-old
child, 10% of energy intake is equivalent to 450 ml of soft
drink (just over one can) whereas 10% of energy expenditure
is equivalent to 2.5 h extra walking.46
The use of consistent methods and common health
outcome measures enables valid comparison of the potential
impact of the 13 interventions presented in this example
(Table 3), but comparisons should take into account the
strength of the evidence used. When we consider the
strength of evidence alongside the size of the total DALY
benefit (Figure 1), decisions on what interventions are likely
to be effective when implemented become more complex.
Decisions to invest in interventions in the top left hand
corner of Figure 1 are less risky because the evidence
supporting a high potential health gain is much stronger.
Thus, the chance of success in improving population health
is higher. But, these interventions on their own are unlikely
to be sufficient to address the current levels of overweight
and obesity, let alone to prevent the future predicted increase
in overweight and obesity. Thus, some tough decisions will
need to be made – and these are more risky because the
return is less certain. For example, the evidence supporting
the reduction in TV advertising to children is less strong.
Although there is a randomized controlled trial supporting
the link between advertising and unhealthy food choice, the
relationship between food choice and BMI was modelled
based on lower levels of evidence. Thus, whereas the
potential health gain is high, the certainty that it will be
achieved if the intervention is implemented is lower. For this
reason, we recommend that, if implemented it (and all
interventions that fall in the right hand section of Table 2
and Figure 1) should be accompanied by an appropriate
evaluation plan and budget so that the size of the actual
impact on BMI can be determined using a controlled study
design (level II or III57). Changes to the intervention can
then be made, if needed, based on better quality evidence. If
not shown to be effective, the resources should then be
diverted appropriately.
Another consideration in setting priorities for obesity
prevention is the appropriate mix of clinical/targeted
interventions versus public health interventions. Clinical
interventions, whereas more likely to have an immediate
and larger impact on individuals, are insufficient to reverse
the trend towards increasing BMI.64 Real impacts on the
problem will only occur if clinical approaches are comple-
mented by public health prevention approaches that focus
on the whole population with the aim of changing social
norms and moving the entire distribution of BMI to the
left.64 The need to intervene across a range of settings and
sectors should also be considered for maximum effect.5
Methodological advances
We chose to develop new methods rather than exclude all
interventions that did not have randomized controlled
evidence of a change in BMI, which would have reduced
the project’s usefulness to policy makers. We used the best
available evidence to model from changes in behaviour to
changes in BMI. We also developed a new evidence grading
system based on the degree of confidence that we thought
could be put in the results for interventions that relied on
evidence of effectiveness from level IV study designs and
other types of evidence (see right hand column of Table 2).
Although both of these approaches increase the uncertainty
around the benefit estimate we believe that this is preferable
to allowing selective decision-making to continue where
interventions with poorer quality evidence are implemented
solely on the basis of political acceptability without
consideration of their potential health gain or cost-
effectiveness. But we reiterate that, if implemented, these
interventions must be properly evaluated to confirm their
effectiveness and to enable modifications to be made if
needed.
Another methodological advance in this project was to
model from post-intervention changes in BMI to DALYs
saved over the child’s lifetime using the best available
evidence. DALYs are particularly useful because they allow
comparisons to be made between interventions in children
and adults as well as between interventions addressing other
disorders or risk factors. The use of a utility measure such as
the DALY also allows ‘benchmarking’ with existing pharma-
ceutical and medical interventions.
Another strength of the ACE-Obesity project methods
described in this paper is the inclusion of future predicted
trends in BMI, deaths and morbidity to 30 years in the
future. Although adding uncertainty to the model, it
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improves its overall accuracy. Further, the treatment of BMI
as a continuous rather than categorical variable (i.e. normal
weight, overweight or obese) gives more valuable informa-
tion on overall population impact of interventions and is
consistent with the latest methodological advances made in
assessing the burden of disease attributable to high BMI.15
Our use of simulation-modelling techniques to allow multi-
way uncertainty analysis around the BMI benefit is another
strength of our methods.
Limitations of the methods
The biggest limitation of the ACE-Obesity project methods is
the assumption that 100% of the BMI benefit is maintained
over the lifetime. This is unlikely, with the exception of the
‘Laparoscopic adjustable gastric banding’ intervention, as
behavioural changes are difficult to maintain. Thus, the
DALY benefit is likely to be lower than reported, unless
implementation of multiple obesity prevention interven-
tions had some kind of synergistic and multiplicative effect –
which is currently unknown and untested. Also, if the
intervention effort was maintained it could be postulated
that the BMI benefit would be maintained as well. We tested
the impact of the alternative assumptions that only 50 and
25% of the effect is maintained. The results indicate that the
benefits are similarly reduced by approximately 50 and 25%,
respectively. Although it is very likely that the size of the
maintenance of the effect varies between interventions,
there is insufficient evidence on which to base quantitative
modelling. It is important to acknowledge that if all of the
benefit is lost by the time the child reaches 25 years of age
(the age at which disease risks begin to be included in the
model) then the resulting DALYs saved will be zero.
This highlights another limitation of the model: that
impacts on diseases in childhood and adolescence are not
included, nor is any impact on quality of life, that is,
independent of disease. However, this was a deliberate
decision because there is a lack of reliable epidemiological
evidence that any childhood conditions are causally related
to obesity2 or that BMI has an impact on quality of life,
independent of disease. Other limitations of the ACE-
Obesity project methods include the number of assumptions
needed to translate from behaviour change to BMI to DALYs,
as well as the inability to include uncertainty around all of
these assumptions/estimates in our multi-way uncertainty
analyses.
The lack of good quality evidence of effectiveness for many
public health interventions, including some interventions
that have already been widely implemented in Australia, was
a significant limitation of the ACE-Obesity project. Although
the reasons for not measuring BMI changes owing to an
intervention are understandable (although not always well
justified), the reasons for not including both pre- and post-
intervention measurement of the targeted behaviour
(e.g. physical activity or food choice), let alone an appro-
priate control group, are much less understandable and need
to be addressed. In an era of greater demand for evidence-
based policy-making and where the need to maximize the
health gain achieved from limited resources is more
apparent, it is imperative that funders of public health
programmes ensure that what is implemented is properly
evaluated. This information can then aid future decision-
making.
Gaps in the knowledge base
As well as providing evidence of the health benefit likely to
be achieved by various obesity interventions, the ACE-
Obesity study has highlighted many information gaps that
need to be addressed by further research. The most obvious is
the need for new and more effective initiatives for primary
prevention in particular. The expected gain from the current
arsenal of interventions is unlikely to be sufficient to reverse
the trend towards increasing levels of overweight and
obesity. And any new or current interventions that are
tested or implemented, need to be properly evaluated so that
we can be confident that they actually achieve the desired
impact when compared to current practice or to no
intervention – be it an increase in physical activity levels, a
decrease in consumption of energy-dense foods and drinks
and/or a slowing of the increase in BMI. Impact on
satisfaction levels or retrospective reporting of baseline
behaviours is insufficient evidence on which to base funding
decisions if the desire is to prove an impact on obesity or
physical activity levels. Population-based cohort studies are
also needed to properly assess the causal relationship
between BMI in childhood and later health effects in
children and adolescents, including type 2 diabetes and
early signs of cardiovascular disease. The population pre-
valence of type 2 diabetes in children and adolescents also
needs to be measured objectively and periodically to confirm
the clinical and anecdotal evidence of its reported increase in
recent years.2,65
Extrapolation of the health benefit results to other countries and
health systems
In the ACE-Obesity study we used the Australian context to
determine the likely health benefit (and costs). Therefore,
care must be taken if trying to generalize the results to other
countries. Some interventions may work differently in other
countries, particularly behavioural interventions, owing to
differences in lifestyle, culture, beliefs, education and health
systems and current practice in obesity prevention. The
impact on total BMI units and DALYs saved will also vary
according to differences in population size and structure and
different BMI distributions and disease rates between
countries. Ideally, analyses should be repeated for other
countries so that these factors can be taken into account
before application in policy-making.
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Conclusions
In conclusion, the results of these analyses provide valuable
information on the health benefit likely to be achieved by 13
different interventions for the prevention of obesity in
children and adolescents. Because we have used consistent
methods and common health outcomes (BMI and DALYs),
the impact of these interventions can be validly compared.
However, conclusions drawn from these comparisons should
take into account the strength of the evidence used in
determining the health benefit. Other considerations that
will be important and are to be presented in future
ACE-Obesity papers are: the cost-effectiveness of the inter-
ventions and broader aspects that impact on real world
decision-making, including acceptability to stakeholders,
feasibility of implementation, sustainability, impact on
equity and potential positive and negative side-effects.
Acknowledgements
We thank members of the ACE-Obesity working group for
their input into the project: Michael Ackland (Deputy
Chair), Bill Bellew, John Catford, Elizabeth Develin, Helen
Egan, Bonnie Field, Tim Gill, John Goss, Robert Hall (Chair),
Brian Harrison, Kellie-Ann Jolly, Mark Lawrence, Amanda
Lee, Tony McBride, Karen McIntyre, Jan Norton, Anna
Peeters, Melissa Wake and Rowland Watson. We also thank
the other researchers who have worked on the project as part
of their postgraduate studies: Jaithri Ananthapavan, Leah
Galvin, Margaret MacDonald and Margaret Rumpf.
References
1 International Food Information Council. Trends in obesity
related media coverage. 2006 (accessed August 2006); Available
from: http://www.ific.org/research/obesitytrends.cfm.
2 Lobstein T, Baur L, Uauy R. Obesity in children and young people:
a crisis in public health. Obes Rev 2004; 5 (Suppl 1): 4–104.
3 Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-
Effectiveness in Health and Medicine. Oxford University Press:
New York, 1996.
4 Vos T, Haby MM, Magnus A, Mihalopoulos C, Andrews G, Carter
R. Assessing cost-effectiveness in mental health: helping policy-
makers prioritize and plan health services. Aust NZ J Psychiatry
2005; 39: 701–712.
5 Swinburn B, Gill T, Kumanyika S. Obesity prevention: a proposed
framework for translating evidence into action. Obes Rev 2005; 6:
23–33.
6 Doak CM, Visscher TL, Renders CM, Seidell JC. The prevention of
overweight and obesity in children and adolescents: a review of
interventions and programmes. Obes Rev 2006; 7: 111–136.
7 Summerbell CD, Waters E, Edmunds LD, Kelly S, Brown T,
Campbell KJ. Interventions for preventing obesity in children
(Cochrane review). Cochrane Database of Systematic Reviews 2005;
Art No.: CD001871.
8 Segal L, Mortimer D, Dalziel K. Risk factor study: how to reduce
the burden of harm from poor nutrition, tobacco smoking,
physical inactivity and alcohol misuse: cost-utility analysis of 29
interventions, executive report. Research Paper 2005 (1). Centre
for Health Economics, Monash University: Melbourne 2005.
9 Wang LY, Yang Q, Lowry R, Wechsler H. Economic analysis of a
school-based obesity prevention program. Obes Res 2003; 11:
1313–1324.
10 Carter R, Stone C, Vos T, Hocking J, Mihalopoulos C, Peacock S
et al. Trial of Program Budgeting and Marginal Analysis (PBMA) to
assist cancer control planning in Australia, Research Report 19.
Centre for Health Program Evaluation: Melbourne, 2000.
11 Liew D, Lim SS, Bertram M, McNeil JJ, Vos T. A model for
undertaking effectiveness and cost-effectiveness analyses of
primary preventive strategies in cardiovascular disease. Eur J
Cardiovasc Prevent Rehab 2006; 13: 515–522.
12 Haby MM, Carter R, Mihalopoulos C, Magnus A, Sanderson K,
Andrews G et al. Assessing cost-effectiveness – mental health:
introduction to the study and methods. Aust NZ J Psychiatry 2004;
38: 569–578.
13 Carter R. The Macro Economic Evaluation Model (MEEM): an
approach to priority setting in the health sector (PhD thesis).
Monash University: Melbourne, 2001.
14 Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC
et al. Systematic review of the long-term effects and eco-
nomic consequences of treatments for obesity and implications
for health improvement. Health Technol Assess 2004; 8(21):
1–194.
15 James WPT, Jackson-Leach R, Mhurchu CN, Kalamara E, Shayeghi
M, Rigby NJ et al. Overweight and obesity (high body mass
index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL (eds).
Comparative Quantification of Health Risks: Global and Regional
Burden of Disease Attributable to Selected Major Risk Factors. Geneva:
World Health Organization, 2004. pp 497–596.
16 National Obesity Taskforce. Healthy Weight 2008 – Australia’s
Future – The National Action Agenda for Children and Young People
and their Families. Department of Health and Ageing: Canberra,
2003.
17 Australian Government. Active After-School Communities Pro-
gram. 2005 (accessed 20 August 2006); Available from: http://
www.healthyactive.gov.au/internet/healthyactive/publishing.nsf/
Content/initiatives-a.
18 Mo-suwan L, Pongprapai S, Junjana C, Puetpaiboon A. Effects of a
controlled trial of a school-based exercise program on the
obesity indexes of preschool children. Am J Clin Nutr 1998; 68:
1006–1011.
19 Sallis JF, McKenzie TL, Alcaraz JE, Kolody B, Hovell MF, Nader PR.
Project SPARK. Effects of physical education on adiposity in
children. Ann NY Acad Sci 1993; 699: 127–136.
20 Dwyer T, Coonan WE, Leitch DR, Hetzel BS, Baghurst RA. An
investigation of the effects of daily physical activity on the health
of primary school students in South Australia. Int J Epidemiol
1983; 12: 308–313.
21 Tamir D, Feurstein A, Brunner S, Halfon ST, Reshef A, Palti H.
Primary prevention of cardiovascular diseases in childhood:
changes in serum total cholesterol, high density lipoprotein,
and body mass index after 2 years of intervention in Jerusalem
schoolchildren age 7–9 years. Prev Med 1990; 19: 22–30.
22 Manios Y, Moschandreas J, Hatzis C, Kafatos A. Evaluation of a
health and nutrition education program in primary school
children of Crete over a three-year period. Prev Med 1999; 28:
149–159.
23 Foster GD, Wadden TA, Brownell KD. Peer-led program for the
treatment and prevention of obesity in the schools. J Consult Clin
Psychol 1985; 53: 538–540.
24 James J, Thomas P, Cavan D, Kerr D. Preventing childhood
obesity by reducing consumption of carbonated drinks: cluster
randomised controlled trial. Br Med J 2004; 328: 1237–1243.
25 Ebbeling CB, Feldman HA, Osganian SK, Chomitz VR, Ellenbogen
SJ, Ludwig DS. Effects of decreasing sugar-sweetened beverage
consumption on body weight in adolescents: a randomized,
controlled pilot study. Pediatrics 2006; 117: 673–680.
Health benefit from obesity interventions in children and adolescents
MM Haby et al
1474
International Journal of Obesity
26 Robinson TN. Reducing children’s television viewing to
prevent obesity: a randomized controlled trial. JAMA 1999; 282:
1561–1567.
27 Gortmaker SL, Peterson K, Wiecha J, Sobol AM, Dixit S, Fox MK
et al. Reducing obesity via a school-based interdisciplinary
intervention among youth: Planet Health. Arch Pediatr Adolesc
Med 1999; 153: 409–418.
28 DiPietro G, Hughes I. TravelSMART Schools – there really is a
better way to go. 26th Australasian Transport Research Forum;
Wellington, New Zealand; 2003. Available from: http://www.
travelsmart.vic.gov.au/Web4/tsmart.nsf/.
29 VicHealth. Walking School Bus. 2006 (accessed 20 August 2006);
Available from: http://www.vichealth.vic.gov.au/Content.aspx?
topicID¼23.
30 Victoria University. The Walking School Bus Program. Learnings
from VicHealth’s pilot program 2001. VicHealth: Melbourne,
2003.
31 Gorn G, Golberg M. Behavioural evidence of the effects of
televised food messages to children. J Consum Res 1982; 9:
200–205.
32 McCallum Z, Wake M, Gerner B, Harris C, Gibbons K, Gunn J
et al. Can Australian general practitioners tackle childhood
overweight/obesity? Methods and processes from the LEAP (Live,
Eat and Play) randomized controlled trial. J Paediatr Child Health
2005; 41: 488–494.
33 Flodmark CE, Ohlsson T, Ryden O, Sveger T. Prevention of
progression to severe obesity in a group of obese schoolchildren
treated with family therapy. Pediatrics 1993; 91: 880–884.
34 Israel AC, Stolmaker L, Andrian CAG. The effects of training
parents in general child management skills in a behavioural
weight loss program for children. Behav Ther 1985; 16: 169–180.
35 Kirschenbaum DS, Harris ES, Tomarken AJ. Effects of parental
involvement in behavioural weight loss therapy for preadoles-
cents. Behav Ther 1984; 15: 485–500.
36 Senadiak CSS. Rapid versus gradual scheduling of therapeutic
contact in a family-based behavioural weight control programme
for children. Behav Psychother 1985; 13: 265–287.
37 Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of
orlistat on weight and body composition in obese adolescents: a
randomized controlled trial. JAMA 2005; 293: 2873–2883.
38 Abu-Abeid S, Gavert N, Klausner JM, Szold A. Bariatric surgery in
adolescence. J Pediatr Surg 2003; 38: 1379–1382.
39 Avinoah E. Laparoscopic gastric banding for morbidly obese
adolescents. Surg Laparosc Endosc Percutaneous Tech 2004; 14: 350.
40 Fielding GA, Duncombe JE. Laparoscopic adjustable gastric
banding in severely obese adolescents. Surg Obes Relat Dis 2005;
1: 399–405.
41 Hayr T, Widhalm K. Laparoscopic gastric banding in morbidly
obese adolescents. Ann Nutr Metab 2003; 47: 427.
42 Widhalm K, Dietrich S, Prager G. Adjustable gastric banding
surgery in morbidly obese adolescents: experiences with eight
patients. Int J Obes 2004; 28: S42–S45.
43 Mathers C, Vos T, Stevenson C. The burden of disease and injury
in Australia. AIHW cat. no. PHE 18. Australian Institute of Health
and Welfare: Canberra 1999. (also available at) http://www.aihw.
gov.au/publications/.
44 Public Health Group. Victorian Burden of Disease Study: Mortality
and Morbidity in 2001. Department of Human Services: Mel-
bourne, 2005.
45 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for
examining heterogeneity and combining results from several
studies in meta-analysis. In: Egger M, Smith GD, Altman DG
(eds). Systematic Reviews in Health Care: Meta-Analysis in Context
2nd edn. BMJ Publishing Group: London, 2001. pp 285–312.
46 Swinburn BA, Jolley D, Kremer PJ, Salbe AD, Ravussin E.
Estimating the effects of energy imbalance on changes in body
weight in children. Am J Clin Nutr 2006; 83: 859–863.
47 Rolls BJ. The role of energy density in the overconsumption of
fat. J Nutr 2000; 130: 268S–271S.
48 Rolls BJ, Roe LS, Meengs JS. Reductions in portion size and energy
density of foods are additive and lead to sustained decreases in
energy intake. Am J Clin Nutr 2006; 83: 11–17.
49 Cook P, Rutishauser IHE, Seelig M. Comparable Data on Food and
Nutrient Intake and Physical Measurements from the 1983, 1985 and
1995 National Nutrition Surveys. Commonwealth Department of
Health and Aged Care: Canberra, 2001.
50 McLennan W. Australian Bureau of Statistics. Information paper:
National Nutrition Survey, confidentialised unit record file, 1995.
Australian Bureau of Statistics: Canberra, 1998.
51 Bell AC, Kremer PJ, Magarey AM, Swinburn BA. Contribution of
‘noncore’ foods and beverages to the energy intake and weight
status of Australian children. Eur J Clin Nutr 2005; 59: 639–645.
52 Australian Department of Health & Ageing. Australian Guide to
Healthy Eating. Australian Department of Health & Ageing:
Canberra, 1998.
53 Ludwig DS, Peterson KE, Gortmaker SL. Relation between
consumption of sugar-sweetened drinks and childhood
obesity: a prospective, observational analysis. Lancet 2001; 357:
505–508.
54 Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM,
Strath SJ et al. Compendium of physical activities: an update of
activity codes and MET intensities. Med Sci Sports Exerc 2000; 32:
S498–S504.
55 Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ.
Selected major risk factors and global and regional burden of
disease. Lancet 2002; 360: 1347–1360.
56 Vos T, Goss J, Begg S, Mann N. Australian Burden of Disease and
Injury Study: Projected Health Care Costs Report. School of Popula-
tion Health, University of Queensland and Australian Institute of
Health and Welfare: Brisbane, 2005.
57 National Health and Medical Research Council. A Guide to the
Development, Implementation and Evaluation of Clinical Practice
Guidelines. NHMRC: Canberra, 1999.
58 Hawe P, Shiell A. Preserving innovation under increasing
accountability pressures: the health promotion investment
portfolio approach. Health Promot J Aust 1995; 5: 4–9.
59 NHMRC National Breast Cancer Centre Psychosocial Working
Group. Psychosocial Clinical Practice Guidelines: Information, Sup-
port and Counselling for Women with Breast Cancer. National Health
and Medical Research Council: Canberra, 2000.
60 Loxley W, Toumbourou JW, Stockwell T. The Prevention of
Substance use, Risk and Harm in Australia: A Review of the Evidence.
The National Drug Research Institute and the Centre for
Adolescent Health: Canberra, 2004.
61 Rychetnik L, Frommer M. A Schema for Evaluating Evidence on
Public Health Interventions; Version 4. National Public Health
Partnership: Melbourne, 2002.
62 World Bank. World Development Report 1993: Investing in Health.
Oxford University Press: New York, 1993.
63 Ezzati M, Lopez AD, Rodgers A, Murray CJL (eds). Comparative
Quantification of Health Risks: Global and Regional Burden of Disease
Attributable to Selected Major Risk Factors. World Health Organiza-
tion: Geneva, 2004.
64 Rose G. Sick individuals and sick populations. Int J Epidemiol
1985; 14: 32–38.
65 McMahon SK, Haynes A, Ratnam N, Grant MT, Carne CL, Jones
TW et al. Increase in type 2 diabetes in children and adolescents
in Western Australia. Med J Aust 2004; 180: 459–461.
Health benefit from obesity interventions in children and adolescents
MM Haby et al
1475
International Journal of Obesity
